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Bovine mastitis, prevalent in dairy cattle, is often caused by a bacterial infection in 
the mammary gland. Bovine mastitis is costly to the dairy industry for loss of milk 
production.  
Causative bacteria are determined by microbiological culture. Culture remains 
popular for its low cost, simple procedure and interpretation however, has limitations. 
Culture based assays are subjective, timely and may not support fastidious organisms. Nearly 
30% of clinical mastitis cases are culture-negative especially in cows treated with antibiotics. 
Treated cows with negative milk cultures may indeed still be infected, shedding low numbers 
of bacteria that do not appear in culture causing false negative results. 
One potential alternative to culture is a commercial assay, PathoProof™ Mastitis 
PCR Assay (ThermoFisher Scientific, Waltham, MA). PathoProof is capable of detecting 11 
mastitis-causing bacteria from milk. To evaluate PathoProof, the analytical specificity and 
limit of detection (LOD) was determined using 20 culture isolates of target and non-target 
bacteria. The LOD was determined by inoculating phosphate-buffered saline and milk with 
three different bacteria. Serial dilutions, standard plate count and PCR were performed. 
Further evaluation used cows that were treated with antibiotics for mastitis. Milk samples 
were collected from cows on days 0, 3, 7, 14 and 30 post-treatment. Samples were evaluated 
using culture and PathoProof PCR. 
PathoProof PCR only detected target bacteria from a group of 20 target and non-
target isolates resulting in an analytical specificity of 100%.  Average LOD ranged from 103 
to 104 CFU/mL and 101 to 103 CFU per PCR reaction, relatively high values compared to 
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previous investigations of other mastitis PCR assays. The high LOD suggests concerns about 
false negative results from cows shedding bacteria at low levels. 
Data from 25 cows treated for mastitis were used to compare culture to PathoProof. 
More cows were PCR-positive on days 3, 7, 14 and 30 post-treatment demonstrating that 
PathoProof may be helpful in detecting bacteria in milk from treated cows. Information from 
PathoProof may be useful in evaluating efficacy of treatment and assist veterinarians and 
producers in making decisions. Further investigation into the assay’s sensitivity and 




 INTRODUCTION: THESIS FORMATTING 
 
 This thesis is organized into 4 chapters. Chapter 1 outlines the format of the thesis. 
Chapter 2 entitled “Review of bovine mastitis etiology and diagnostic methods” reviews 
general information about mastitis and current research in mastitis diagnostics. Chapter 3, 
“Quantitative and qualitative evaluation of real-time PCR in the detection of bovine mastitis 
pathogens” follows chapter 2. Chapter 4 is titled, “Evaluation of conventional bacteriological 
culture and real-time PCR for detection of bacteria in milk from cows treated for mastitis” 
followed by chapter 5 “General Conclusions.” Tables and figures adjoining each chapter will 








Mastitis or intramammary infection refers to inflammation of the mammary gland and 
may affect all mammals. It has particular importance in the dairy industry affecting the 
quantity and quality of milk produced by infected cows resulting in significant economic 
losses. There are nearly 9.3 million dairy cows in the United States responsible for 100 
million tons of milk (USDA-ERS, 2015) produced yearly. Purported as the perfect food, milk 
and milk products represent a significant source of protein and minerals required in the 
human diet. Maximizing milk production while maintaining the welfare of cows is a complex 
system of balancing animal nutrition, housing, animal reproduction, milking procedures and 
health. 
Bovine mastitis is the most common cause of decreased milk production in dairy 
cattle which further implies the importance of prevention and control of this costly disease 
and protection of the global food supply (ADSA and Jones, 2006). The ever increasing need 
for resources to support the growing global population places the burden on food producers 
to maximize efficiency to meet increased demands. 
 
The U.S. dairy industry 
  The U.S. dairy industry has experienced dramatic changes due to rapid growth during 
the past century. The American Dairy Science Association (ADSA) was formed to increase 
dairy production through advancements in animal health, genetic selection and farm 
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technologies. Since their establishment in 1906, the ADSA has collected data regarding the 
status of the dairy industry in the U.S along with government agencies such as the U.S. 
Department of Agriculture (USDA) and the Food and Drug Administration (FDA).  
  The previous century’s dairy industry was considerably smaller and less efficient 
when dairy cattle remained in numbers less than ten to provide families with a source of food 
rather than a source of income. Between 1930 and 2014, the annual per capita consumption 
of dairy products in the U.S. increased to 614 pounds (USDA-ERS, 2015). Due to increased 
demands,  the average size of dairy herds increased from 5 to 115 cows with an average 
annual milk production of 4,500 pounds in 1930 to nearly 20,000 pounds per cow in 2006 
(ADSA and Jones, 2006). This advancement could not have come without great strides in 
farming technologies. 
Automated milking became standard in the 1940s by use of vacuum milking units 
that attached to all 4 teats to collect milk through controlled pulsation (ADSA and Jones, 
2006). Vacuum pulsation is used in modern milking facilities and reduces milking time and 
labor per cow. Automatic milking has also increased milk yield through proper emptying of 
the udder and has helped limit the transfer of microorganisms (Thompson, 1980). 
 
Etiology of bovine mastitis 
Since the advent of automated milking and the efficiency it brings, dairy operations 
have been able to expand herd size and operations by decreasing the time, labor and materials 
spent milking each cow. These advancements in technology have also improved sanitation 
methods but even in well-sanitized dairy operations, cows are still constantly exposed to 




Clinical mastitis is the presence of inflammation of the mammary gland and may be 
attributed to injury or infection from any pathogenic microorganism due to invasion through 
the teat canal. Clinical signs are most often detected during premilking procedures that are 
performed by farm employees. Premilking procedures include the application of an 
antimicrobial solution to each teat, removal of excess soil and manure with cloth towels and 
the removal of foremilk also known as “forestripping” prior to attaching milking equipment 
(Hogan et al., 1999). In between milking times, bacteria present on the skin or environmental 
organisms from soil or manure may migrate into the teat canal and possibly further into the 
mammary gland. To prevent these organisms from entering the bulk tank and potential cross-
contamination between cows, stripped foremilk is observed for color and consistency. 
Visible changes in the milk’s consistency may include clotting, flaking and the presence of 
blood. Indications of clinical mastitis are not limited to changes in the milk. External redness 
and swelling of the udder, tenderness to the touch, heat and palpable abscesses may also be 
present in clinical mastitis cases (Hogan et al., 1999). 
Subclinical mastitis 
Subclinical mastitis is defined as the absence of physical signs of inflammation to the 
udder and is the most common form of mastitis (Orlandini, 2011). It is primarily detected by 
increased somatic cell count (SCC) in the milk when increased numbers of white blood cells 
are recruited to the mammary gland due to mild infection or trauma (Orlandini, 2011). The 
SCC is expressed in cells per milliliter (mL) of milk and maintains high significance in the 
dairy industry and is routinely measured on individual cows and from milk collected from the 
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bulk tank. Somatic cell counts of 200,000 cells per mL or higher is indicative of 
inflammation (Hogan et al., 1999).  
Immunity of the mammary gland 
  The mammary gland is protected by physical and chemical factors that impede the 
invasion of microorganisms. Bacteria must enter through the teat orifice that is controlled by 
sphincter muscles that relax during milk removal or let-down and requires 2 hours to fully 
contract after completion of milking (Srivastava et al., 2015). If microorganisms pass through 
the teat orifice they contact the teat canal, a cylindrical duct located inside the teat opening. 
The stratified epithelium lining the teat canal secretes keratin, a waxy, physical barrier that 
forms a plug that exits the teat during initial milk ejection and reforms after milking is 
completed (Rainard and Riollet, 2006). Keratin also provides a chemical defense with 
bacteriostatic and bactericidal compounds that include long chain fatty acids. A previous 
study demonstrated an infection rate of approximately 26.3% for quarters that had the keratin 
removed prior to milking followed by exposure to Streptococcus agalactiae after the milking 
process suggesting the importance of keratin as a preventative against mastitis (Capuco et al., 
1992). Despite keratin’s protective effect, some bacteria have the ability to migrate into the 
mammary gland and cause infection. 
Innate immune responses are critical during the initial stage of mastitis to respond to 
infection by different pathogens after they invade the mammary gland. The first to recognize 
the release of bacterial compounds are toll-like receptors (TLR), proteins embedded in 
leukocytes and epithelial cell membranes that recognize pathogen associated molecular 
patterns (PAMPS) such as lipopolysaccharides or peptidoglycan fragments (Rainard and 
Riollet, 2006; Salyers and Whitt, 2002; Wellnitz and Bruckmaier, 2012). After the 
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stimulation of TLR’s by invading bacteria inflammation is mediated by polymorphonuclear 
neutrophilic (PMN) leukocytes which are recruited in vast numbers from the blood to the 
mammary tissue (Wellnitz and Bruckmaier, 2012). PMNs engulf and destroy the bacteria 
using intracellular granules that contain bactericidal enzymes and proteins such as superoxide 
ions, hypochlorite, hydrogen peroxide and hydrolytic enzymes (Wellnitz and Bruckmaier, 
2012). When expended, PMNs will lyse and are subsequently engulfed by macrophages and 
destroyed (Salyers and Whitt, 2002). 
Somatic Cell Count 
  Leukocytes inevitably end up in milk due to their massive numbers in response to 
infection in the mammary gland. In bovine mastitis leukocytes, macrophages, secretory and 
squamous cells are collectively referred to as somatic cells that are measured in individual 
and bulk tank samples, a value called somatic cell count (SCC) (Norman et al., 2011). An 
SCC level reflects the health of the udder or the health of the herd. SCC also has significance 
in quality determination by the Food and Drug Administration, the governing body of milk 
regulation. According to the 2015 Grade “A” Pasteurized Milk Ordinance (PMO), milk of 
grade “A” status may not have a bulk tank somatic cell count greater than 750,000 cells/mL 
of raw milk (FDA, 2015). Although somatic cells in milk have not been found to pose a 
health risk to humans (Hogan, 2005), SCC is a reflection of the hygiene practices of the 
operation (Moxley et al., 1978).  
For the determination of mastitis, limits have been set at 200,000 cells/mL or greater 
as an indicator of inflammation (Norman et al., 2011). SCC is particularly useful in 
diagnosing subclinical mastitis as there are no visible clinical signs in the milk and has 
become a routine practice in mastitis diagnostics. Methods to determine SCC as approved by 
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the FDA are direct microscopic somatic cell count (DMSCC) or electronic somatic cell count 
(ESCC). DMSCC is the reference method performed by dispensing milk on a glass slide and 
staining with methylene blue dye allowing somatic cell nuclei to be visualized and counted 
(Orlandini, 2011).  
Vaccines 
  There are many reports that have investigated the use of vaccines for prevention of 
bovine mastitis (Pereira et al., 2011). Currently, few vaccines are commercially available for 
preventing mastitis. The obvious challenge to developing a broadly efficacious bovine 
mastitis vaccine is the large variety of bacteria known to cause mastitis (Watts, 1988). 
Another challenge to develop mastitis vaccines is inducing long term immunity when the 
target bacterium may change antigenically or with subtypes of bacteria specific to different 
regions and herds. Vaccine development has primarily targeted mastitis caused by 
Staphylococcus aureus and Escherichia coli (Pereira et al., 2011) likely due to the 
pathogenicity and high prevalence of cases (Makovec and Ruegg, 2003; Oliveira et al., 2013; 
USDA-APHIS, 2008). 
 Pereira et al. published an extensive review of S. aureus vaccine studies and 
developed a scoring system to determine the efficacy of published methods. Their findings 
indicated that the use of recombinant proteins associated with S. aureus provided 50% 
protection in experimentally infected quarters. One of the reviewed studies, Carter and Kerr, 
2003, performed this method using protein A, a virulence factor of S. aureus, encoded on a 
staphylococcal plasmid which was then transfected into cells that were injected into animals. 
Pereira et al. also reported 50% protection using inactivated vaccines known as bacterins or 
inactivated toxins known as toxoids. One such study (Leitner et al., 2003) achieved success 
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using a bacterin and toxoid from 3 different strains of S. aureus with different hemolysis 
patterns. 
Contagious and Environmental Mastitis 
  Bovine mastitis is classified into two different types according to the origin of the 
organism and mode of exposure. Contagious mastitis is associated with several pathogens 
with the ability to be transmitted between cows and exist in low numbers in the environment. 
Environmental mastitis is caused by a variety of organisms found in the cow’s environment 
originating from manure, soil, water or bedding. However, once a cow is infected, they will 
shed the organism into the environment or milking equipment with the ability to transmit the 
pathogen to another animal.  
Contagious Mastitis  
Staphylococcus aureus 
Perhaps the most significant mastitis pathogen, Staphylococcus aureus, has been 
isolated from individual cow and bulk tank milk samples in 43% of U.S. dairy operations in 
the top 17 milk-producing states according to a USDA-APHIS study in 2007. Mastitis caused 
by S. aureus may present as clinical, subclinical and chronic infections in cows (Srivastava et 
al., 2015). S. aureus is associated with diseases of several body systems in humans and has 
become a critical public health concern with its increasing resistance to antimicrobials. 
 The Staphylococcus genus refers to a Gram-positive coccoid bacterium often 
arranged in groups or clusters. Colony morphology is large, white or yellow mucoid colonies 
on agar plates. Staphylococci are catalase positive and exhibit gamma or beta hemolysis 
although S. aureus is usually beta hemolytic. S. aureus is a common skin inhabitant of 
humans and the udder of cows. Most S. aureus infections affecting the skin are opportunistic, 
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requiring damage to the epidermis such as lacerations, abrasions and burns, to cause 
infection. S. aureus primarily affects dairy cows by intramammary infection and represents 
the most economically devastating mastitis pathogen (Oliver et al., 2004).  
Some species of staphylococci produce coagulase, which is an important surface 
protein that is commonly used to differentiate S. aureus from other Staphylococcus spp. 
although it is not the only coagulase-positive Staphylococcus species. Coagulase proteins 
produced by some staphylococci are considered a virulence factor although coagulase itself is 
not directly involved in pathogenesis. Coagulase induces clumping of the blood by forming a 
complex with fibrinogen and prothrombin, two blood proteins involved in the clotting 
cascade (Graber et al., 2009). Coagulase mediates adherence to mammalian cells, such as red 
blood cells, that is thought to disguise the bacterium as a host protein to prevent recognition 
by the immune system (Salyers and Whitt, 2002). Coagulase status is determined by rinsing 
pure culture into rabbit sera in a tube or on a slide. The formation of a gel or coagulation of 
the serum indicates the bacterium contains the coagulase enzyme (Boerlin et al., 2003). 
 S. aureus has a variety of extracellular enzymes found in bovine mastitis isolates 
including staphylokinase, hyaluronidase, phosphatase, nuclease, lipase and catalase. These 
enzymes are thought to assist S. aureus in survival and spread in the host by destroying 
extracellular matrices or making milk components available as an energy source for the 
bacterium (Salyers and Whitt, 2002; Sutra and Poutrel, 1994). Exact mechanisms of their 
pathogenesis are not known. 
Streptococcus agalactiae 
Streptococcus agalactiae is a significant contagious pathogen in bovine mastitis with 
a high propensity to transmit from cow to cow, lacking the ability to thrive in the 
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environment. It causes clinical and subclinical mastitis in dairy cattle passing from cow to 
cow by the hands of milking staff, cleaning rags used on cows as well as milking machines 
(Hogan et al., 1999). When 530 U.S. dairy operations had milk from bulk tanks sampled, 
2.6% cultured positive for S. agalactiae, a low percentage compared to S. aureus or E.coli 
which were both above 40% (USDA-APHIS, 2008).  
The Streptococcus genus represents nonmotile, gram-positive coccoid bacteria often 
arranged in chained patterns. These catalase negative bacteria tolerate oxygen but may prefer 
anaerobic conditions and perform fermentative metabolism. They exhibit alpha, beta, and 
gamma hemolysis in culture and present as small to medium sized colonies (Oliver et al., 
2004).  
  Little is understood about the virulence of S. agalactiae. One potential virulence 
factor was observed in human infections was found with the production of maternal antibody 
to its capsular polysaccharides suggesting the capsular polysaccharides may cause clinical 
symptoms (Salyers and Whitt, 2002). Bovine isolates contain the gene hylB encoding 
hyaluronidase, an enzyme capable of cleaving the extracellular matrix in tissues (Sukhnanand 
et al., 2005).  
Mycoplasma species 
Mycoplasma is a genus of bacteria associated with contagious bovine mastitis. The 
most prevalent Mycoplasma species is Mycoplasma bovis however, 11 additional species 
have been isolated from bovine mastitis (Oliver et al., 2004). Mycoplasma spp. is considered 
a fastidious organism that requires 10% CO2 in a 37°C incubator for 7 to 10 days on culture 
media (Hogan et al., 1999). Mycoplasma spp. lack a cell wall so are resistant to antibiotics 
that target the cell structure (Bürki et al., 2015).  
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 Mycoplasma spp. also perpetrate respiratory infections, arthritis, otitis and genital 
infections in cows thus providing numerous potential reservoirs in a dairy operation (Bürki et 
al., 2015). Little is understood about the molecular mechanisms of pathogenicity of 
mycoplasmal species. Their small genomes provide a few processes that allow Mycoplasma 
spp. to adhere and survive in hosts. Adherence to host cells, heavily mediated by surface 
proteins, is critical for this organism as they lack biosynthetic pathways to acquire essential 
resources such as amino acids. M. bovis has been found to invade alveolar epithelial cells in 
the bovine mammary gland which may contribute to its ability to disseminate throughout the 
host (Bürki et al., 2015). 
Environmental mastitis 
Environmental Streptococcus spp. 
Mastitis caused by streptococci species are attributed to Streptococcus dysgalactiae and 
Streptococcus uberis. Other environmental streptococci known to cause mastitis are S. 
acidominus, S. canis, S. equi, and S. equinus. These pathogens have been isolated from the 
intestinal tract and manure of dairy cattle which may contaminate bedding (Oliver et al., 
2004). In dairy operations, concentrations of streptococci in bedding may reach 106 CFU/g in 
wood shavings, recycled manure and pelleted corn (Todhunter et al., 1995).  
 Pathogenicity of environmental streptococci is not well understood however several 
mechanisms allow streptococci to thwart host immunity and adhere to and invade host cells. 
S. dysgalactiae and S. uberis interact with host proteins fibronectin, fibrinogen, 
immunoglobulins, collagen and laminin which enables the bacteria to adhere to host cells. S. 
dysgalactiae contains hyaluronidase and fibrinolysin believed to allow the bacterium to 
disseminate in host tissue. The capsule of S. uberis allows it to avoid phagocytosis however, 
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similar capsule formation has not been observed in S. dysgalactiae. Both species have been 
found inside mammary secretory cells thought to involve host cell kinases and rearrangement 
of microfilaments (Calvinho et al., 1998).  
Coliforms 
 Coliforms are gram-negative bacteria that ferment lactose to produce gas and are 
associated with the gastrointestinal system of animals. Coliforms are responsible for animal 
health and food safety concerns because they can be pathogenic and also reflect the hygienic 
practices of dairy operations and food processors. The presence of coliforms in any product 
suggests contamination with fecal material through manure, sewage or run-off. This material 
is likely to harbor bacteria responsible for foodborne-illness. Grade “A” milk may not 
contain greater than 10 coliform bacteria per mL of raw milk upon arrival at the processing 
plant according to the 2015 PMO (FDA, 2015).  
  Coliform bacteria are abundant in the environment of dairy operations (Hogan et al., 
1999). The most common coliforms that can cause mastitis are E. coli, Klebsiella 
pneumoniae or oxytoca, and to a lesser extent Citrobacter species and Enterobacter species 
(Makovec and Ruegg, 2003; Oliveira et al., 2013). Bacterial isolation from milk is often 
achieved with selective and differential media including MacConkey’s agar which is 
selective for gram-negative organisms and differentiates them based on their lactose 
fermentation result.  Growth appears at 18 hours when incubated at 37°C. Further 
identification is often performed with differential biochemical tests for gas production, 
motility and carbohydrate substrate utilization (Oliver et al., 2004).   
 E. coli is the most common cause of coliform mastitis (Makovec and Ruegg, 2003; 
Oliveira et al., 2013) with the ability to induce mild to severe symptoms for a short duration. 
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The pathogen is often eliminated by the cow’s immune system without treatment (Döpfer et 
al., 1999; Wenz et al., 2006). E. coli, like other gram negative organisms, possess an outer 
membrane composed of antigenic lipopolysaccharide (LPS) the component that induces the 
initial immune response and inflammation after infection (Salyers and Whitt, 2002). There 
are few consistent virulence factors among E. coli bovine mastitis isolates (Fernandes et al., 
2011; Wenz et al., 2006) but they all have components that cause an immune reaction and 
allow better colonization of the organism (Shpigel et al., 2008). One of these is the ability to 
form biofilms on the mammary alveolar epithelial cells (Shpigel et al., 2008) thought to be 
mediated by type I fimbriae (Fernandes et al., 2011). Fernandes et al. further concluded that 
the majority of E. coli isolates analyzed from bovine mastitis were of a genotype associated 
with commensal E. coli found in the GI tract indicating cows are exposed when they come 
into contact with manure or soiled bedding. 
  Klebsiella is another opportunistic bacterial species found in a dairy cow’s 
environment. Klebsiella pneumoniae has become significant in human medicine in the 
ongoing battle with multidrug resistant bacteria in hospital environments (Diancourt et al., 
2005). Klebsiella pneumoniae resists attack by PMNs due to a thick polysaccharide capsule 
production that surrounds the outer membrane of the bacterium (Kanevsky-Mullarky et al., 
2014). This capsule also makes K. pneumoniae distinguishable on an agar plate due to the 
mucoid appearance of the colonies (Oliver et al., 2004). 
Enterococcus species 
Enterococcus species were originally thought to be members of the Streptococcus 
genus and innocuous to dairy cows. Enterococcus species has risen in clinical occurrence in 
hospital environments. Like streptococci, Enterococcus spp. are gram positive and catalase 
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negative. Where the two genera differ is their reservoirs in animals where enterococci are 
found in the intestinal tract and manure of cows (Oliver et al., 2004) at concentrations near 
that of E. coli (Salyers and Whitt, 2004). 
Viruses 
  With nearly 30% of bovine milk samples submitted to diagnostic laboratories for 
bacteriological culture yielding a no growth result (Makovec and Ruegg, 2003; Oliveira et 
al., 2013) it is possible that a portion of these cases are attributable to viral infections. Most 
viral bovine pathogens do not produce an infection local to the mammary gland but are shed 
through milk due to a systemic viral infection. Viral pathogens associated with dairy cattle 
and isolated from milk include bovine herpes virus (BHV), foot and mouth disease (FMD), 
parainfluenza (PI), bovine leukemia virus, vaccinia, cow pox, vesicular stomatitis, bovine 
papilloma virus, bovine viral diarrhea virus, rinderpest virus and bovine enterovirus 
(Wellenberg et al., 2002).  Clinical mammary symptoms present as classic inflammation such 
as swelling and tenderness of the udder, fever and failure to thrive. Subclinical signs include 
an increased SCC and decreased milk production. Viruses BHV1, FMD, PI3 have induced 
clinical mastitis after experimental introduction through the intramammary route and BHV4 
has induced subclinical mastitis. However, natural induction through the mammary gland is 
not common due to their susceptibility to the environment (Wellenberg et al., 2002).  
Diagnosis of bovine mastitis 
Dairy practitioners and herd managers use a variety of tools to diagnose mastitis in an 
animal before the next step of pathogen detection. Most often, somatic cell count (SCC), 
which can be determined by several methods, is used to detect mastitis. Other methods such 
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as metal conductivity, visual inspection and animal records assist clinicians in identifying 
mastitis cases. 
PCR/nucleic acid tests for the detection of bovine mastitis  
  The characterization of polymerase chain reaction (PCR) in 1985 by Kerry Mullis 
incited a substantial change to virtually all areas of biological science. PCR allowed scientists 
to choose a segment of deoxyribonucleic acid (DNA) and exponentially increase the amount 
of DNA in a sample for further analysis. The first nucleic acid assays for use with bovine 
milk were developed to detect pathogens that are difficult to cultivate in the laboratory. 
Various PCR assays were used to detect Mycobacterium avium ssp. paratuberculosis 
(Johne’s disease) (Over et al., 2011), Mycobacterium bovis (Antognoli et al., 2001; 
Sreevatsan et al., 2000), Brucella spp. (Romero and Lopez-Goñi 1999; Sreevatsan et al., 
2000), Coxiella burnetii (Muramatsu et al., 1997), Cryptosporodium spp. (Laberge et al., 
1996), and Mycoplasma spp. (Baird et al., 1999).  
Before nucleic acid assays can be performed the genetic material must be extracted 
and purified from the sample. Protocols developed for bacterial DNA extraction directly 
from clinical samples must reduce or eliminated inhibiting substances naturally occurring in 
the sample that can reduce the sensitivity of the assay. Milk contains fat, carbohydrates, 
protein and minerals that impede the isolation of bacterial DNA. Calcium ions in milk can 
affect DNA replication by interfering with the magnesium cofactor of polymerase. Milk 
proteins impede DNA polymerase by acting as a physical barrier by sequestering the target 
DNA and primers. Bacterial cellular debris and polysaccharides have shown similar ability to 
physically block DNA polymerase by the target DNA and primers (Wilson, 1997). Raw milk 
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samples are often combined with enrichment media to dilute these factors (Gillespie and 
Oliver, 2005; Rossen et al., 1992). 
 For bovine mastitis diagnostics, PCR was originally used for the detection of 
Mycoplasma spp., an optimal candidate for PCR diagnostics due to its fastidious nature in 
culture. In 1999, Baird et al. developed a nested PCR assay to detect Mycoplasma spp. DNA 
present in bulk tank milk, individual cow milk and enriched liquid cultures with success. In a 
2001 study by Riffon et. al. a multiplex PCR assay able to detect several mastitis pathogens 
was evaluated. S. aureus, S. agalactiae, S. dysgalactiae, S. uberis, S. parauberis and E. coli 
cultures were inoculated into UHT (ultra-high temperature) pasteurized milk where samples 
were exposed to methods including a pre-enzymatic lysis and methods without a pre-
enzymatic lysis step. Two different primer sequences were used for each pathogen target 
representing the16s and 23s rRNA genes to ensure specificity between related species. High 
specificity was achieved in this analysis with all targets properly amplified and detected and 
non-targets presenting no amplification. Analytical sensitivity of the assay was 3.12x102 
CFU/mL of milk with the pre-PCR enzymatic lysis and 5x103 CFU/mL of milk from the 
process that did not include a pre-PCR enzymatic lysis step. The authors chose to investigate 
the effect on sensitivity without a pre-PCR lysis step to reduce the costs of reagents. It is 
evident that without a pre-PCR lysis step some sensitivity is sacrificed and will have to be 
considered with the assay’s use.   
 Another multiplex PCR analysis was used for the detection of S. agalactiae, S. uberis, 
S. dysgalactiae, and S. aureus in bulk tank milk samples in Australia. Phuektes et al. sampled 
bulk tanks every 10 days for 5 collections from 42 farms for 176 samples comparing PCR to 
bulk tank somatic cell count (BTMSCC) and total bacteria count (TBC). Although the study 
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did not directly compare culture and PCR for the detection of S. agalactiae, S. uberis, S. 
dysgalactiae, and S. aureus, results indicated that PCR was able to detect the four organisms 
from bulk tank milk according to their methods. 
 Real-time multiplex PCR was first studied for use with bovine milk for mastitis 
pathogens in 2005 by Gillespie and Oliver. Species-specific primer/probe sets were designed 
based on separate studies validating individual real-time PCR assays for the detection of S. 
agalactiae, S. uberis and S. aureus. The study compared 2 commercial methods and one 
additional method of extracting bacterial DNA from milk samples. The most reproducible 
results came from the use of the enzyme pronase which acts on the casein protein, 
dismantling the micelle that forms with calcium and phosphorus ions, which can interfere 
with the PCR reaction. Analytical specificity was 100% performed with 47 non-target ATCC 
strains of 31 target bacterial species. Limit of detection (LOD) or analytical sensitivity was 
determined using UHT pasteurized milk inoculated with the three organisms with subsequent 
serial dilutions. The LOD of S. aureus was 103 CFU/mL and the LOD for S. agalactiae and 
S. uberis was 102 CFU/mL. All 3 organisms achieved an LOD of 100 CFU/mL with an 
overnight enrichment step. The assay was then tested against 192 mastitis quarter milk 
samples with conventional culture results indicating an analytical sensitivity of 95.5% and 
specificity of 99.6% for target and non-target pathogens. Increased sensitivity was observed 
when 20 S. aureus and S. uberis positive milk samples were enriched with culture broth and 
incubated overnight and compared to non-enrichment PCR results. It was proposed that the 
improvement was due to dilution of the inhibitory substances found in milk and the increased 
growth due to the addition of nutrient broth and incubation time. The potential concern with 
enriching milk samples is the high likelihood of milk samples being contaminated from the 
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environment or the udder skin. Enrichment allows for the propagation of environmental 
contaminants that are in low numbers in the original sample and when tested with PCR could 
deliver a false positive result prolonging testing time. 
 PathoProof Mastitis PCR 
  PathoProof™ Mastitis PCR was the first commercial multiplex, real-time PCR assay 
capable of simultaneously detecting eleven bovine mastitis pathogens and one resistance 
gene. The test was developed by Finnzymes Oy of Espoo, Finland and is currently 
manufactured by ThermoFisher Scientific Inc. of Waltham, Massachusetts. The assay is 
contained in a kit providing all the reagents needed to extract bacterial DNA from bovine 
milk and perform real-time PCR. The assay is offered in several forms designated the major-
3, complete-12 and complete-16, each identifying significant bovine mastitis pathogens. All 
kits are compatible with different extraction equipment and thermocycler systems including 
the KingFisher 96 deepwell automatic extraction using magnetic particle processing and the 
Applied Biosystems® 7500 Fast thermocycler (both manufactured by ThermoFisher 
Scientific Inc., Waltham, MA). The complete-12 assay is performed in 4 separate reactions 
containing 3 different primer/probe sets to detect their respective targets. Included in each 
reaction is an internal amplification control (IAC), which is a fragment of DNA that in the 
absence of PCR inhibition should amplify during the reaction and act as a positive control. 
The 4 separate reactions are as follows: primer/probe set 1 detects Staphylococcus aureus, 
Enterococcus species (including E. faecalis and E. faecium), Corynebacterium bovis and an 
IAC primer/probe; set 2 detects Staphylococcus blaZ, the gene encoding beta lactamase 
responsible for resistance to beta-lactam antibiotics, Escherichia coli, Streptococcus 
dysgalactiae and an IAC; primer/probe set 3 detects Staphylococcus species (including 
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coagulase-negative Staphylococcus spp.), Streptococcus agalactiae, Streptococcus uberis and 
an IAC; primer/probe set 4 detects Klebsiella species (including K. oxytoca and K. 
pneumoniae), Serratia marcescens, Trueperella pyogenes and/or Peptoniphilus indolicus and 
an IAC.  
PathoProof assays include the Norden Lab Mastitis Studio software that provides 
interpretation of the data collected by thermocycler systems. The Applied Biosystems® 7500 
Fast system collects data using sequence detection software (SDS) which can be uploaded 
into the Norden software. The data is reported in a standard format provided by Norden that 
includes a list of targets that were determined positive in the assay and their corresponding Ct 
values. The process is simple and produces results in a report suitable for a client. Currently, 
there are publications describing the use of Norden software for analysis with the PathoProof 
assay (Keane et al, 2013; Cervinkova et al, 2013) but not including in-depth discussion of its 
use and result interpretation leaving question as to its accuracy and utility.   
 The first published investigation of PathoProof PCR was in 2007 by Pitkälä et al. 
when it was used in a comparison of different assays to detect beta-lactamase-producing 
Staphylococcus species. One hundred and seventy-five Staphylococcus spp. isolates were 
used in the comparison including S. aureus, S. intermedius, and coagulase-negative species 
including S. epidermidis, S. chromogenes, S. cohnii, S. xylosus, S. hyicus, S. haemolyticus, S. 
warneri, S. saprophyticus and S. simulans all originating from cases of clinical bovine and 
canine mastitis samples. The assays evaluated in this study were compared to a PCR 
reference method for the detection of the beta-lactamase gene sequence. All methods, except 
for PathoProof PCR, compared in this analysis were designed to detect the beta-lactamase 
enzyme while PathoProof PCR was the only assay included to detect the blaZ gene. 
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Compared to the reference method, PathoProof PCR detected all isolates with the beta-
lactamase gene and did not detect the isolates that were determined negative by the reference 
method. PathoProof PCR was the most successful method in detecting beta-lactamase 
producing Staphylococcus spp. of all the methods compared in the study. The authors 
recommended PathoProof for routine beta-lactamase producing Staphylococcus testing 
however given that the assay is multiplexed and developed to extract bacterial DNA from 
bovine milk samples making it was impractical for the detection of single pathogens isolated 
from pure culture (Pitkälä et al., 2007).  
An extensive validation study of PathoProof PCR was published in 2009 by Koskinen 
et al. with the title, “Analytical specificity and sensitivity of a real-time polymerase chain 
reaction assay for identification of bovine mastitis pathogens.” Koskinen et al. collected 643 
culture isolates originating from bovine, human and companion animal mastitic milk samples 
from diagnostic laboratories dispersed over a wide geographical range. Targets included 525 
isolates including 72 blaZ gene-positive staphylococci isolates used and validated by Pitkälä 
et al., 2007. One-hundred and eighteen isolates were non-target species. The original culture 
results obtained by the respective laboratories were compared to PathoProof PCR results that 
became the basis of Koskinen et al. specificity and sensitivity analysis. In cases where target 
isolates did not match their PathoProof PCR result, 16s rRNA sequencing and comparison 
was completed. 
PathoProof PCR was successful in properly identifying 634 of the 643 isolates 
including all isolates originating from bovine mastitis with no false negative results. Nine 
isolates were found falsely positive by PathoProof PCR as confirmed by 16s rRNA 
sequencing including Streptococcus pyogenes, Streptococcus sanguis, Streptococcus 
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salivarius identified as S. uberis, and 1 Shigella spp. isolate identified as E. coli. The authors 
of the study reported a 100% analytical specificity for all PathoProof targets except for S. 
uberis at 99% and E. coli at 99.5% and a 100% analytical sensitivity for all targets using 
false positive and negative equations. It should be noted that this study did not apply a 
consistent, standard method to identify all culture isolates. 
The objectives in this study were to define the analytical sensitivity and specificity of 
the PathoProof assay however analytical sensitivity is defined as the lowest concentration 
that is detectable by the assay, expressed in a numerical value (Saah and Hoover, 1997). Such 
figure was not described in this study despite its title. What was performed in this study more 
closely resembled a diagnostic sensitivity analysis by testing closely-related, non-target 
species however diagnostic sensitivity for PathoProof should be determined using clinical 
milk samples according to the definition of diagnostic sensitivity (Saah and Hoover, 1997). 
Analytical sensitivity is important to diagnosticians as some samples may have low 
concentrations of target. A threshold concentration of bacteria in a sample that signifies 
bovine mastitis has not been established in any literature therefore an established analytical 
sensitivity of PathoProof PCR may not directly translate into a diagnosis. However, 
analytical sensitivity is still valuable when evaluating an assay and that has yet to be 
determined for the PathoProof PCR. 
PathoProof PCR research continued with “Real-time polymerase chain reaction-based 
identification of bacteria in milk samples from bovine clinical mastitis with no growth in 
conventional culturing” published in 2009. The objectives in this study were to address 
PathoProof PCR as a potential solution to the frequent culture-negative results in cows with 
clinical mastitis. Using 79 milk samples that were negative or no-growth in culture, the 
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authors used PathoProof PCR to detect bacteria in 43% of the milk samples tested. The Ct 
values obtained for the bacterial targets ranged from 22.2 to 36.7 with an average of 32.3. 
Detected targets included S. uberis (10), S. dysgalactiae (2), S. aureus (3), T. pyogenes (1), E. 
faecalis/faecium (1), E. coli (1), Staphylococcus species (9) and C. bovis (5) with some 
samples positive for 2 targets. The average Ct was relatively high indicating low 
concentration of target which is consistent with the negative culture results that are attributed 
to low concentrations of bacteria in a sample. Of the positive targets discretion may be 
needed for culture-negative samples that are positive for Staphylococcus spp. and C. bovis as 
they are 2 common skin inhabitants making them common contaminants in milk collections. 
A separate Ct threshold of significance for these 2 organisms may improve interpretation.   
This study also investigated the quantitative abilities of PathoProof PCR by creating a 
standard curve to find the concentration of copy numbers in a sample. The authors used the 
kit’s amplification standard, DNA concentration, amplicon length and mass to calcluate the 
amount of genome copies per mL of milk. The lowest Ct value among all of the samples was 
22.2 for Staphylococcus spp. which corresponded to 1.7x103 copies in the original milk 
sample. The results of this study are helpful for interpretation of Ct values for diagnostic 
purposes however similar work with empirical methods to determine the LOD is necessary to 
understand PathoProof PCR abilities. 
Another study using bovine milk samples was published in 2010 by Koskinen et al. 
comparing culture to PathoProof PCR. The authors collected 780 quarter milk samples from 
clinical mastitis cases as well as 220 samples from cows without clinical indications of 
mastitis. Culture methods consisted of selective and differential media to isolate and identify 
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bacteria according to the standards of the National Mastitis Council. The authors did not 
further specify their culture identification methods. 
The results showed culture able to detect bacteria in 77% of samples and PathoProof 
detected bacteria in 89% of the clinical milk samples. Of the 220 samples from cows with no 
clinical signs of mastitis, 46 of them were found to have subclinical mastitis with SCC 
ranging from 296,000 to 4,011,000 cells/mL. Of the 46 subclinical milk samples, culture 
detected bacteria in 83% of samples and PathoProof PCR detected bacteria in 92%. The 
authors reported high agreement between PCR and culture identifications. As seen in the 
previously discussed study, a significantly higher amount of the culture negative/PCR 
positive samples were positive for C. bovis and Staphylococcus spp. which could be a result 
of environmental contamination. 
Future use of PathoProof PCR 
It is clear that PathoProof PCR requires further research in order to assess its value as 
a diagnostic aid for bovine mastitis. As discussed previously, an analytical sensitivity must 
be established to determine whether PathoProof is able to detect low concentrations of 
bacteria, an ability that may be compromised in culture testing. An analytical sensitivity 
value would also assist diagnosticians in understanding the relative quantity of bacteria based 
off of Ct values. Although, some quantitative analysis in copies per mL has been performed 
by Taponen et al., 2010 the study did not find the minimum and maximum limits the assay 
was able to detect. Genomic copy number/mL may not directly translate into CFU/mL and 
CFU/mL is the most relevant to bovine mastitis. LOD values for this assay can be found by 
inoculating milk with known concentrations of bacteria then serially diluting the milk and 
performing standard plate count to get an accurate concentration in CFU/mL. PCR should 
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then be performed on all of the dilution samples to find the last dilution that is detected by 
the assay; this dilution should have the highest Ct value.  
According to Makovec and Ruegg, 2003 and Oliveira et al., 2013 nearly one-third of 
clinical milk samples submitted for culture are negative or no-growth. Several potential 
causes have been proposed such as low concentration of bacteria in a sample, fastidious 
organisms with nutritional requirements beyond what typical culture provides, inhibition by 
milk compounds or milk from cows receiving intramammary antimicrobial treatment. 
Taponen et al., 2009 and Bexiga et al., 2011 reported finding bacterial DNA in 43% and 47% 
of clinical milk samples with negative culture results suggesting PathoProof PCR may be 
able to overcome some of the circumstances that cause clinical milk samples to be negative 
in culture. The use of PathoProof in these circumstances has not been investigated. 
Because molecular assays are typically more costly to perform, PathoProof PCR must find its 
niche in bovine mastitis diagnostics to make it worth the extra cost. One potential niche may 
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CHAPTER 3. QUANTITATIVE AND QUALITATIVE EVALUATION OF REAL-
TIME PCR IN THE DETECTION OF BOVINE MASTITIS PATHOGENS 
 
Abstract 
Bovine mastitis is a common and costly disease of dairy cows and continues to be a 
persistent problem in the dairy industry. Bacterial infections are the most common cause of 
mastitis and can be detected through microbiological culture. Culture is the current gold 
standard diagnostic test to detect mastitis-associated bacteria although it does not favor the 
growth of fastidious organisms or bacteria in low concentrations. An alternative to culture is 
the use of PCR assays. PathoProof™ Mastitis PCR is a commercial multiplex real-time PCR 
assay capable of detecting 11 common bacteria associated with bovine mastitis. Analytical 
specificity was evaluated using the 11 target bacteria and 9 non-target isolates from a bovine 
mastitis teaching set and clinical isolates. Analytical sensitivity was evaluated using three 
bacterial isolates and serial dilutions in phosphate buffered saline (PBS) and milk to compare 
standard plate counts and PCR to determine a limit of detection. Data was analyzed using the 
manufacturer’s Norden Lab Mastitis Studio software as well as the ABI 7500 Sequence 
Detection Software (SDS). PathoProof demonstrated 100% specificity detecting only the 
target bacteria. The limit of detection for PathoProof PCR was 104 CFU/mL which is lower 
than expected causing concern for false negatives in samples with concentrations below that 
limit. The Norden software analysis generated different results compared to the SDS 
software supplied by the ABI 7500. The Norden results were found to be false positives 
caused by non-sigmoidal curves that were not consistent with real-time PCR results. 
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PathoProof PCR has the potential to be an alternative diagnostic tool to bacterial culture 
when used with SDS software and careful observation of real-time PCR graphs. 
 
Introduction 
Mastitis or intramammary infection (IMI) causes decreased milk production and 
economic loss to dairy farmers affecting all dairy operations (Hogan et al., 1999). Bacteria 
are the most common cause of mastitis after invasion and colonization of the mammary 
gland. The bacteria most commonly detected in bovine mastitis include Staphylococcus 
aureus, coagulase-negative Staphylococcus species, environmental Streptococcus species and 
coliform bacteria such as Escherichia coli (Makovec and Ruegg, 2003; Watts, 1988). 
Bacterial infections of the mammary gland can manifest as clinical or subclinical mastitis 
although both result in decreased milk production (Watts, 1988). Preventing mastitis relies on 
adequate sanitation of both the lactating cow and the milking environment. Successful 
treatment requires rapid identification of causative agents and subsequent segregation and 
treatment of affected animals (Wilson et al., 1999). Multiple tests are available to diagnose 
mastitis in affected cows and can be used to help evaluate success of treatment (Viguier et 
al., 2009). However, diagnosing mastitis is a time consuming process and requires sensitive, 
specific and rapid diagnostic tests.  
 Bacterial culture of aseptically collected milk samples is considered the gold standard 
method for diagnosing mastitis (Hogan et al., 1999). Bacterial cultures are relatively simple 
to conduct, economical and have been well validated. With the proper media and incubation 
conditions, most bacterial causes of bovine mastitis can be cultivated in the laboratory with 
subsequent antibiotic sensitivity to help guide treatment decisions. However, limitations of 
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culture may include the length of incubation prior to detection, difficulty isolating fastidious 
organisms or lack of bacterial growth due to antibiotic treatment or other unknown reasons. 
Alternative methods that may help detect or diagnose mastitis are needed. One option is the 
use of real-time, multiplex PCR (qPCR).  
 In 2008 a commercial multiplex qPCR kit known as PathoProof Mastitis PCR™ 
(ThermoFisher Scientific, Waltham, MA) was approved for use to detect several common 
bacterial causes of bovine mastitis. The qPCR kit provides the reagents necessary to extract 
bacterial DNA directly from milk and conduct qPCR. The Complete 12 kit offers 
primer/probe sets for the following organisms: Staphylococcus aureus, coagulase negative 
Staphylococcus species, Streptococcus agalactiae, Streptococcus uberis, Streptococcus 
dysgalactiae, Enterococcus faecalis/faecium, Escherichia coli, Klebsiella 
pneumoniae/oxytoca, Corynebacterium bovis, Trueperella (Arcanobacterium) pyogenes/ 
Peptoniphilus indolicus and Serratia marcescens. In addition, PathoProof PCR is able to 
detect the Staphylococcus spp. beta lactamase gene blaZ responsible for beta-lactam 
antimicrobial resistance.  
 Real-time PCR may be used as an alternative to culture due to several advantages. 
One difference between culture and PCR is the time it takes from processing samples to 
delivery of results. Within 4 hours, DNA extraction and real-time PCR with simultaneous 
detection of all 12 targets is completed. In contrast, bacterial culture requires at least 48 hours 
to allow enough time for fastidious mastitis pathogens, such as Trueperella pyogenes, to 
grow (Oliver et al., 2004). Furthermore, only viable bacteria are detected by culture. 
However, PathoProof PCR does not distinguish between viable and non-viable bacteria in a 
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sample and may complicate the ability to distinguish between infected and recovering 
animals.  
One favorable aspect of culture has been the low cost to the dairy producer to perform 
the assay. Generally, PCR is more costly due to its requirement of more expensive equipment 
and trained technicians. Milk culture does not require extensive laboratory training or 
experience to perform the assay but additional training may be necessary for interpretation of 
the results. Bovine milk samples are easily contaminated during collection due to the 
presence of microbiota on the skin and environmental organisms, which must be considered 
when interpreting milk cultures. Populations of bacteria on culture plates must be evaluated 
for significance making the results highly subjective. PathoProof PCR delivers a list of 
detected pathogens with corresponding Cts. 
 Accompanying the PathoProof PCR kit is the interpretive software, Norden Lab 
Mastitis Studio (ThermoFisher Scientific, Waltham, MA). The PathoProof PCR kit and 
Norden software are compatible with 3 different real-time PCR systems including the 
Applied Biosystems™ 7500 Fast (ThermoFisher Scientific, Waltham, MA). Norden software 
uses the data collected from the real-time PCR instrument to produce a report containing 
cycle threshold values (Cts) for the detected targets. The software applies target-specific Ct 
ranges that correspond to a low (+), moderate (++) and high (+++) quantity of target. The 
Norden program issues results in a well-ordered format that can be easily understood by 
veterinarians and herd managers; Use of the Norden software for analysis of PathoProof data 
has been reported previously (Keane et al., 2013; Cervinkova et al., 2013) but its 
interpretation has not been addressed. 
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 Several studies have analyzed the diagnostic specificity and sensitivity and analytical 
specificity of PathoProof PCR (Keane et al., 2013; Koskinen et al., 2009; Taponen et al., 
2009;Wellenberg et al., 2010) however an established analytical sensitivity, or limit of 
detection (LOD) concentration, has not been determined. The objectives of this study were to 
a) determine the analytical specificity using an array of complete 12 target and non-target 
bacterial isolates and b) determine the limit of detection in colony forming units per milliliter 
(CFU/mL) using target bacterial dilutions spiked into phosphate buffered saline (PBS) and 
milk and c) compare cycle threshold values between Norden Lab Mastitis Studio software 
and the Applied Biosystems Sequence Detection System (SDS) software. 
 
Materials and Methods 
Specificity evaluation bacterial culture 
Bacterial isolates used in the specificity analysis were obtained from the Iowa State 
University Veterinary Diagnostic Laboratory (ISU VDL) Clinical Microbiology Laboratory 
from a bovine mastitis teaching set. All 11 bacterial targets included in the PathoProof 
complete 12 kit were used for specificity analysis as well as 9 non-target bacteria. The eleven 
bacterial targets included Staphylococcus aureus, Staphylococcus simulans (coagulase-
negative staphylococci), Streptococcus agalactiae, Streptococcus uberis, Streptococcus 
dysgalactiae, Enterococcus faecalis, Escherichia coli, Klebsiella pneumoniae, 
Corynebacterium bovis, Trueperella pyogenes and Serratia marcescens. Nine non-target 
bacterial and fungal species isolated from bovine mastitis cases at the ISU VDL used in this 
evaluation included Citrobacter koseri, Lactobacillus gasseri, Pasteurella multocida, yeast, 
Pseudomonas aeruginosa, Enterobacter cloacae, Lactococcus garvieae, Enterococcus 
saccharolyticus and Streptococcus pluranimalium. Identity of bacteria were confirmed by 
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matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF 
MS) which has been used previously to identify bovine mastitis pathogens (Barreiro et al., 
2010; Schabauer et al., 2014). Results from the MALDI-TOF MS were reported on a log 
scoring system with values between 0 and 3. Scores of 1.7 or higher are considered reliable 
for genus-level identification and scores higher than 2 are considered reliable for species 
identification (Barreiro et al., 2010). 
DNA extraction 
Bacteria were cultured on 6% sheep blood agar and incubated for 24 hours at 37° C. 
Using a sterile plastic loop, 5 bacterial colonies were selected and suspended directly in the 
lysis solution provided by the PathoProof DNA extraction kit. Subsequent steps for 
extracting bacterial DNA were performed with the KingFisher Flex Purification System 
(ThermoFisher Scientific, Waltham MA) for DNA purification by magnetic particle 
processing according to the kit’s protocol.  
Real-time PCR 
PathoProof qPCR was conducted according to the manufacturer’s instructions. Four 
separate PCR reactions with primer/probes for three of the 12 targets as well as an internal 
amplification control (IAC) for each set are used in this assay. Each PCR run used a negative 
control to monitor cross-contamination. PathoProof PCR targets are listed in Table 1.  
  The PathoProof real-time PCR profile for use with the Applied Biosystems 7500 Fast 
real-time PCR system consists of 10 minutes at 95°C, followed by 40 cycles of 5 seconds at 
95°C and one minute at 60°C and a final stage of 5 seconds at 25°C. Ct data was collected 





To translate analytical sensitivity into CFU/mL, unpasteurized bovine milk and PBS 
were inoculated with pure culture of three different organisms and serially diluted for 
standard plate count. The organisms included were Streptococcus dysgalactiae, 
Staphylococcus aureus and Escherichia coli. The turbidity standard, 0.5 McFarland (108 
CFU/mL), was created separately for each organism in sterile saline using a nephelometer. 
One milliliter of the 0.5 McFarland, acting as the 100 sample, was transferred to 9mL of PBS 
followed by 8 consecutive 10-fold dilutions. One hundred microliters of each dilution were 
dispensed and spread with a sterile plastic loop on a 20mL plate of 6% sheep blood agar. A 
0.5 McFarland turbidity standard was also created in PBS in which 1mL was transferred to 
9mL of unpasteurized, PCR-negative bovine milk followed by 8 consecutive 10-fold 
dilutions. Similar to the PBS dilutions, one hundred microliters of each milk dilution were 
dispensed and spread with a sterile plastic loop on a 20mL plate of 6% sheep blood agar. 
Cultures were incubated at 37° C for 48 hours and colonies counted. Serial dilutions and 
standard plate counts were performed in triplicate for each organism/diluent combination. An 
aliquot of 400μL of each dilution was used for DNA extraction and subsequent qPCR 
according to the manufacturer’s protocol. 
 
Results 
Analytical specificity of PathoProof qPCR 
The PathoProof qPCR correctly detected the eleven bacterial target isolates included 
in the assay, S. aureus, S. simulans (coagulase-negative staphylococci), S. agalactiae, S. 
uberis, S. dysgalactiae, E. faecalis, E. coli, K. pneumoniae, C. bovis, T. pyogenes and S. 
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marcescens. The bacteria used for the specificity analysis were also identified by MALDI-
TOF MS with scores from each isolate above 2.0 (Table 2). The range of Ct values across all 
organisms detected by PathoProof and SDS analysis was 17.89 to 33.93 with an average of 
21.77. The 9 non-target isolates, C. koseri, L. gasseri, P. multocida, T. montevideense (yeast), 
P. aeruginosa, E. cloacae, L. garvieae, E. saccharolyticus and S. pluranimalium, were also 
supported by MALDI-TOF MS analysis scores above 2.0 excluding S. pluranimalium and T. 
montevideense (Table 3). The S. pluranimalium and T. montevideense both received scores 
above 1.7 confirming identification to the genus level and T. montevideense was confirmed 
as a yeast organism with a Gram stain. All 9 non-target isolates were undetected by the 
PathoProof qPCR assay under the conditions of this study. 
PathoProof qPCR data analysis 
PCR data collected by SDS was transferred to the Norden software program. 
Subsequent Norden analysis correctly detected the bacterial target in the sample but also 
incorrectly reported bacteria not included in this analysis with a wide range of Ct values 
(Table 2). Upon further investigation of the raw qPCR data, extraneous targets were detected 
when the software interpreted atypical fluorescence curves as positive results. This error was 
not observed using the SDS software for qPCR data analysis. 
Analytical sensitivity of PathoProof qPCR  
 Three organisms, S. aureus, E. coli and S. dysgalactiae, spiked into PBS and 
unpasteurized milk were diluted, tested by PathoProof qPCR in triplicate, and subjected to 
standard plate counting. Plates with colony counts in the reliable range of 25 to 250 (FDA, 
2011) were used to calculate total CFU/mL for each dilution. The highest dilution detected 
  
41 
by PCR (the highest Ct) and its corresponding plate count were considered the analytical 
sensitivity or limit of detection (LOD) for that organism/diluent combination.  
The overall mean LOD for all three bacteria was 104 CFU/mL ranging from 103 to 
104 CFU/mL (Table 4). There was no noticeable trend in LOD CFU/mL between PBS and 
milk. The average LOD Ct values ranging from 30.05 to 39.5 demonstrated no discernable 
patterns between organisms and diluent used. 
 
Discussion 
The specificity analysis in this study demonstrated similar results to Koskinen et al. 
2009 where 98% (634 of 643) of target isolates (n=525) and non-target isolates (n=118) were 
correctly detected or undetected, respectively, using PathoProof qPCR. In the current study, 
PathoProof correctly detected the 11 bacterial target isolates included in the assay. 
Conversely, the 9 non-target isolates were not detected by qPCR indicating 100% specificity 
under conditions of this study (Table 2). The staphylococcal blaZ, beta lactamase gene was 
not tested in this study. Beta lactamase-producing staphylococci were studied by Pitkälä et al. 
in which PathoProof PCR was able to correctly identify blaZ gene-positive isolates compared 
to a reference PCR method with 100% sensitivity. The results of this study and others (Keane 
et al., 2013; Koskinen et al., 2009; Taponen et al., 2009; Wellenberg et al., 2010) suggest the 
complete 12 version of the PathoProof qPCR assay is appropriate for accurately detecting 11 
common pathogens isolated from bovine mastitis. However, dairy cows are exposed to a 
variable number of microorganisms in their environment that could cross-contaminate milk 
samples during collection. Therefore, it is necessary PCR assays for detecting mastitis-
associated pathogens are highly specific. Nearly 140 microbial species have been isolated 
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from bovine mastitis cases (Watts, 1988) with variable prevalence  in dairy herds. S. 
agalactiae has reduced in prevalence in recent years (USDA-APHIS, 2008) from a more 
devastating pathogen due to interventions by veterinarians and herd managers such as 
sanitation. S. agalactiae is an example of the way mastitis pathogens change in prevalence 
after intervention making the inclusion of primer/probes for S. agalactiae in a diagnostic 
PCR assay less appropriate due to the decreased likelihood of S. agalactiae infections. 
Typical culture media is capable of growing S. agalactiae without the addition of selective 
ingredients which is more efficient when S. agalactiae are infrequently isolated. Bacterial 
culture’s lack of specificity can be advantageous as it allows many of the nearly 140 
microorganisms isolated from bovine mastitis to propagate (Watts, 1988) as well as limiting 
because cross-contaminating organisms in the sample will grow as well making 
interpretation difficult.  
 To the author’s knowledge this is the first study to report the analytical sensitivity of 
PathoProof PCR in CFU/mL. Analytical sensitivity reflects the concentration at which  the 
target organism can be detected (Saah and Hoover, 1997). Analytical sensitivity is 
determined empirically to achieve a quantifiable value based on the LOD. The method used 
in this study revealed a relatively high LOD of 104 CFU/mL. An assay lacking in sensitivity 
is particularly concerning when working with pooled samples. Sampling all four quarters into 
one container, called composite milk samples, creates the risk of diluting the bacteria to a 
level where they would not be detectable. Composite samples are often used when testing 
cows. The same risk applies to bulk tank milk samples. Bulk tank milk samples are often 
tested for mastitis pathogens using standard plate count to gain an understanding of their 
prevalence within the herd. PathoProof has been evaluated for use on  bulk tank milk 
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(Katholm et al., 2012) where PathoProof was able to detect all 12 targets in bulk tank milk 
from 4,258 herds. The study compared PCR results to culture which was also able to detect 
all 12 targets however the researchers did not perform quantitative analysis by culture. A 
comparison of the quantitative abilities of culture and PathoProof PCR would be instrumental 
in helping herd managers understand the presence as well as prevalence of mastitis pathogens 
in bulk tank milk.  
 Clinical milk samples have been used to compare conventional culture methods to 
PathoProof PCR in previous studies (Cederlöf et al., 2012; Hiitiö et al., 2015; Keane et al., 
2013; Koskinen et al., 2010; Zadoks et al., 2014). With the exception of Hiitiö et al., 
PathoProof PCR detected bacteria in more clinical samples than culture. Two of these studies 
found significant numbers of samples that were culture negative/PCR positive for 
Staphylococcus spp. and C. bovis (Koskinen et al., 2010; Zadoks et al., 2014). 
Staphylococcus spp. and C. bovis are both present as microbiota on the skin of the udder 
making it possible that the high proportion of culture negative/PCR positive is due to the 
contamination of these organisms in low enough numbers that they would be undetected by 
culture. Contamination is taken into consideration when interpreting milk cultures. Limits 
developed by the National Mastitis Council assist in identifying significant growth on a 
culture plate (Hogan et al., 1999). Because PathoProof is semiquantitative, the significance of 
results is not as easily determined.  
 Nearly 30% of clinical milk samples are negative or no-growth in culture for several 
reasons, not all of them known (Makovec and Ruegg, 2003; Oliveira et al., 2013). 
PathoProof PCR has shown success in detecting bacteria in previously culture negative 
samples (Bexiga et al., 2011; Taponen et al., 2009). Raw milk has some natural components 
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bacteriostatic or bactericidal components such as fatty acids, lysozyme, lactoferrin and 
lactoperoxidase (Ekstrand, 1989). Although bacteria can overcome these compounds to cause 
infection in the mammary gland, bacteria may not be able to survive the effects of these 
compounds in a collected milk sample, decreasing the numbers of viable bacteria to an 
undetectable amount. Negative culture results are also observed in cows being treated with 
intramammary antibiotics (Makovec and Ruegg, 2003; Oliveira et al., 2013). PCR is able to 
detect bacteria in the presence of antibiotics or natural inhibitory compounds because it does 
not rely on viable bacteria for detection. This makes PathoProof PCR a suitable test for 
culture negative milk or when cows have been treated with antibiotics.  
 The false positive results observed in the Norden software (Table 2) are concerning as 
its use does not appear to require much real-time PCR experience by the technician. These 
results confirm the importance of evaluating raw PCR data prior to interpreting the results. In 
the study reported here, some of the incorrectly reported Ct values were due to aberrant 
curves that crossed the PCR threshold at Ct values as low as 17.4. The analysis parameters 
used by the Norden software are proprietary and not provided by the manufacturer. The 
aberrant curves were not observed using the SDS software for analysis. SDS was chosen to 
analyze data for all PCR performed for this study.  
 
Conclusion 
PathoProof PCR has performed highly in analytical specificity, achieving 100% 
specificity in this study as well as others. The analytical sensitivity of the assay, 104 
CFU/mL, is concerning and should be further investigated using clinical samples. Real-time 
PCR’s rapid results and semi-quantitative ability are distinct advantages in diagnostic 
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microbiology, the latter of which deserves additional research for this assay. While Norden 
software did not accurately report the results, SDS was able to analyze the PCR data with 
high specificity. PathoProof PCR has the potential to replace bacterial culture however 
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Table 1. PathoProof Mastitis PCR targets included in each PCR reaction.  
(IAC-internal amplification control, blaZ-staphylococcal gene for beta-lactamase) 
 
Table 2. Specificity analysis of bacterial isolates, MALDI-TOF MS scores and PathoProof 
qPCR data analysis using System Detection Software and Norden Mastitis Studio software 
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 Streptococcus uberis  
 IAC 
 Klebsiella species  
 (including K. 
oxytoca and K. 
pneumoniae)  
 Serratia marcescens 
 Trueperella 








































Streptococcus uberis 2.627 S. uberis 21.5 S. uberis 19.2 





Enterococcus faecalis 2.418 Enterococcus spp. 23.0 Enterococcus spp. 21.4 





Klebsiella pneumoniae 2.396 Klebsiella spp. 23.3 Klebsiella spp. 22.0 
Corynebacterium bovis 2.239 C. bovis 18.5 C. bovis 19.9 
Serratia marcescens 2.398 S. marcescens 33.9 S. marcescens 29.1 




Table 3. Specificity analysis of non-target bacterial isolates, MALDI-TOF MS scores and 
PathoProof qPCR data analysis using System Detection Software and Norden 
Mastitis Studio software 
 
Table 4. Analytical sensitivity analysis using S. aureus, S. dysgalactiae and E. coli diluted in 
PBS and milk.
Bacterial Isolate MALDI Score SDS Analysis 
SDS Ct  
Value 
Norden Analysis  
Norden Ct 
Value 
Citrobacter koseri 2.462 Undetected N/A Undetected N/A 
Lactobacillus gasseri 2.363 Undetected N/A Undetected N/A 
Pasteurella multocida 2.342 Undetected N/A Undetected N/A 
Trichosporon montevideense 1.888 Undetected N/A E.coli 29.1 
Pseudomonas aeruginosa 2.468 Undetected N/A Undetected N/A 
Enterobacter cloacae 2.173 Undetected N/A Undetected N/A 
Lactococcus garvieae 2.334 Undetected N/A 




Enterococcus saccharolyticus 2.243 Undetected N/A Undetected N/A 






















S. aureus PBS 9.3x104 7.7x104 
1.1x104 -
1.6x105 
1.2x103 36 2.2 
33.7-
38.0 
S. aureus Milk 2.0x104 7.3x103 
1.2x104 -
2.5x104 





PBS 5.1x103 3.5x103 
1.1x103 -
7.7x103 





Milk 9.2x103 2.1x103 
7.4x103 -
1.2x104 
1.2x102 30.1 0.2 
29.8-
30.2 
E. coli PBS 1.0x104 7.7x103 
1.4x103 - 
1.6x104 
1.4x102 37.6 1.8 
36.3-
39.6 
E. coli Milk 9.9x103 1.4x103 
8.5x103 -
1.1x104 




CHAPTER 4. EVALUATION OF CONVENTIONAL BACTERIOLOGICAL 
CULTURE AND REAL-TIME PCR FOR DETECTION OF BACTERIA IN MILK 




One of the most economically important diseases in the dairy industry is mastitis or 
intramammary infection. Inflammation of the mammary gland is often caused by 
opportunistic bacteria present in the environment that access the mammary gland. Production 
loss and treatment costs are the major sources of financial loss due to bovine mastitis making 
rapid diagnosis and treatment of high importance. Diagnosis is often done using 
microbiological culture, the industry standard for identifying mastitis-causing bacteria. Once 
the causative bacteria are identified proper treatment can be administered. Cows treated with 
intramammary antibiotics often produce negative culture results after subsequent culture due 
to a reduction in magnitude of bacteria remaining in the mammary gland. This can lead to 
false negative results and producers may prematurely consider the cow no longer infected. 
An alternative to culture is PathoProof™ Mastitis PCR (ThermoFisher Scientific, Waltham, 
MA), a real-time, multiplex PCR assay designed to detect 11 common mastitis-associated 
pathogens directly from milk. As PCR detection does not rely on organism viability, it may 
be a more sensitive diagnostic test on milk from cows treated for mastitis. The objective of 
this study was to collect milk samples from cows treated for mastitis and compare 
conventional culture with PathoProof PCR. Culture and PCR results agreed for day 0 in all 
25 cows that were enrolled in the study. The subsequent collections revealed more culture 
negative/PCR positive samples on day 3 (19 cows), 7 (13 cows), 14 (13 cows) and 30 (6 
cows) post treatment initiation. All samples positive on culture were also positive on PCR. 
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The number of culture positive cows declined after day 0 with 1 cow on day 3, 1 cow on day 
7, 3 cows on day 14 and 1 cow on day 30. Although exact mechanisms remain unknown, 
PathoProof PCR may be useful for early mastitis detection or treatment performance in 
treated cows for mastitis. 
 
Introduction 
Mastitis is the inflammation of the mammary gland, and represents a common disease 
in the dairy industry. Bovine mastitis is most often caused by bacterial infections that occur 
through the teat canal colonizing the mammary gland (Hogan et al., 1999). Bovine mastitis 
has significant economic implications for the dairy industry due to cost of treatment, decline 
in milk production and quality and increased labor (Bar et al., 2008). Total costs are 
estimated from $100 to $300 per cow (Bar et al., 2008; Ott, 1999). Additional implications 
associated with mastitis include transmission of mastitis-causing bacteria to uninfected cows 
from milking equipment and the risk of antimicrobial resistant bacteria from the overuse of 
antibiotics (Wilson et al., 1999) that pose a public health threat if disseminated into the food 
supply (Barkema et al., 2006). Over 100 different microbial species have been implicated in 
bovine mastitis (Watts, 1988) and accurate detection is necessary for appropriate treatment.  
 The most common diagnostic method to detect bacteria from cows suspected of 
having mastitis is culture and identification with selective media and biochemical analysis. 
Bacterial culture is considered an accurate and reliable detection method for most common 
mastitis pathogens and remains a popular laboratory method because it is relatively 
inexpensive and simplistic. Culture also has limitations such as the length of time to obtain 
results which may take up to 72 hours. At a minimum, 48 hours are needed to allow bacteria 
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or fungi sufficient time to propagate in the presence of natural antimicrobial compounds in 
milk including immunoglobulins, complement, lysozyme, lactoferrin and lactoperoxidase 
(Ekstrand, 1989; Oliver et al., 2004) or bacteriostatic fatty acids (Hogan et al., 1988). Longer 
incubation times are also necessary to isolate potential fastidious organisms such as 
Trueperella pyogenes or Nocardia species (Oliver et al., 2004). Mycoplasma species is a 
significant and fastidious bovine mastitis pathogen that requires up to 7 days to be cultivated 
in the laboratory using special media and conditions (Oliver et al., 2004). These factors likely 
contribute to the approximate 30% of negative milk cultures reported by diagnostic 
laboratories in spite of the clinical signs observed in affected cows (Makovec and Ruegg, 
2003; Oliveira et al., 2013). Restrictions of bacterial culture have provoked exploration and 
development of new technologies to more rapidly and accurately detect mastitis pathogens.  
 Several diagnostic methods have been investigated to replace or supplement 
conventional bacterial culture. Multiple immunoassays have been developed for mastitis and 
food safety pathogens such as Staphylococcus aureus, Streptococcus agalactiae and Listeria 
monocytogenes (Viguier et al., 2009). Immunoassays are not an ideal replacement for culture 
because most are only capable of detecting one target. Polymerase chain reaction (PCR) has 
been proposed as a replacement of milk culture especially for most common pathogens such 
as Staphylococcus aureus, Streptococcus agalactiae, Streptococcus uberis, and 
Streptococcus dysgalactiae (Phuektes et al., 2003; Riffon et al., 2001). Conventional PCR 
performed with gel electrophoresis is able to detect bacteria in milk samples at low 
concentrations but is not able to give quantitative information of the targets. Real-time or 
quantitative PCR (qPCR) provides semi-quantitative results by using fluorescent probes 
complimentary to the target sequence bound to a fluorophore molecule that is released and 
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emits light after DNA replication. Probes are used in addition to primer sequences to ensure 
specificity to the target bacteria sequence. Results are reported as the cycle threshold (Ct) 
values reflecting the PCR cycle at which fluorescence reaches a predetermined threshold. 
Cycle threshold values are inversely proportional to the amount of bacterial DNA present in 
the sample. Real-time PCR is a sensitive and specific assay previously evaluated to detect 
mastitis pathogens and aid the diagnosis of mastitis with success (Gillespie and Oliver, 2005) 
although commercial assays were unavailable.  
 PathoProof Mastitis PCR™ (ThermoFisher Scientific, Waltham, MA) is the first 
commercial, real-time, multiplex PCR assay designed to detect common bovine mastitis 
pathogens directly from milk. The complete 12 version detects 11 bacterial targets and 1 blaZ 
gene encoding the Staphylococcus beta-lactamase enzyme. The 11 targets include 
Staphylococcus aureus, coagulase negative Staphylococcus species, Streptococcus 
agalactiae, Streptococcus uberis, Streptococcus dysgalactiae, Enterococcus faecalis/faecium, 
Escherichia coli, Klebsiella pneumoniae/oxytoca, Corynebacterium bovis, Trueperella 
(Arcanobacterium) pyogenes/Peptoniphilus indolicus and Serratia marcescens.  
 PathoProof PCR has been validated in several studies that evaluate the assay’s 
sensitivity and specificity with culture isolates (Koskinen et al., 2009; Pitkälä et al., 2007) 
and clinical milk samples (Cederlöf et al., 2012; Hiitiö et al., 2015; Keane et al., 2013; 
Koskinen et al., 2010; Zadoks et al., 2014).  Nearly one third of clinical milk samples are 
culture negative for a variety of reasons, not all of them known. PathoProof PCR has 
detected bacterial DNA in 47% (Bexiga et al., 2011)  and 43% (Taponen et al., 2009) of milk 
samples from affected quarters that were negative or no-growth results in conventional 
culture. 
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 A disadvantage of any molecular test compared to bacterial culture is cost; in spite of 
faster turn-around times and increased analytical sensitivity. Some instances require a more 
sensitive test to make them worth the extra cost. One example may involve testing milk 
samples from cows treated with intramammary antimicrobial products for mastitis. A cow 
treated with antibiotics may not represent an accurate culture result due to a reduction in the 
quantity of post-treatment bacteria present in the sample. Using an assay such as PCR that 
delivers the sensitivity to detect low levels of bacteria after antibiotic treatment may help 
veterinarians and producers determine treatment efficacy and if a cow’s milk may be 
included back into the bulk tank. Currently, there is a lack of literature evaluating PCR and 
bacterial culture in treated clinical cases of mastitis. The objective of this study was to 
compare PathoProof PCR to bacterial culture in samples collected from cows with clinical 
mastitis during the first thirty days post initiation of antibiotic treatment. 
 
Materials and methods 
Cow selection and milk sample collection 
Cows enrolled in this study came from the Iowa State University Dairy Farm and one 
additional dairy farm in central Iowa. Cows were selected from February 2014 through June 
2015. Mastitis was diagnosed using monthly somatic cell count (SCC), electrical 
conductivity of milk and preliminary culture results if available. Cows were selected for 
antimicrobial therapy by veterinarians and herd managers. All cows received 10mL of a 
commercial cephalosporin antimicrobial treatment delivered by the intramammary route in 
the affected quarter once daily for 5 days. Duplicate milk samples were collected from each 
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affected quarter on day 0, prior to the first dose of antibiotic. Subsequent milk samples were 
collected on days 3, 7, 14 and 30 post treatment initiation.   
Bacterial Culture 
Milk samples were maintained on ice until delivered to the Iowa State University 
Veterinary Diagnostic Laboratory (ISU VDL) to ensure quality. After vortexing one of the 
duplicate samples, 100μL was cultured on 20mL of 6% sheep’s blood agar and MacConkey 
agar. Blood agar plates were incubated at 37°C with 5 to 10% CO2 for 48 hours. MacConkey 
agar plates were incubated for 48 hours at 37°C without CO2. Culture plates containing 1 or 2 
different populations of bacteria with at least 5 colonies were considered significant based on 
the National Mastitis Council’s laboratory guidelines for bovine mastitis milk cultures and 
were selected for subculture (Hogan et al., 1999). Identification of the subcultured bacteria 
was confirmed using matrix assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) (Bruker, Billerica, MA).  
MALDI-TOF MS has been validated for use with isolates selected from clinical 
mastitis cases and is able to identify over 100 different genera (Keys et al., 2004) including 
bovine mastitis pathogens (Barreiro et al., 2010). The isolates are given a log score using 
MALDI-TOF MS that ranges from 0 to 3. Scores of 1.7 or greater are considered accurate to 
a genus level and scores of 2.0 or greater are considered accurate to a species level (Barreiro 
et al., 2010).  
PathoProof mastitis PCR  
DNA extraction of one of the duplicate milk samples was performed by magnetic 
particle processing according to the manufacturer’s protocol in the complete-12 kit using the 
KingFisher™ Flex Purification System (ThermoFisher Scientific, Waltham, MA). Four 
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separate PCR reactions contain primers and probes for three of the 12 targets in the assay as 
well as an internal amplification control (IAC) (Table 1). The PathoProof qPCR was 
conducted using the Applied Biosystems 7500 Fast real-time PCR system (ThermoFisher 
Scientific, Waltham, MA) according to the following profile: 10 minutes at 95°C, followed 
by 40 cycles of 5 seconds at 95°C and one minute at 60°C and a final stage of 5 seconds at 
25°C. Each primer/probe set included an IAC to detect internal inhibitors of PCR and serving 
as a positive control for each reaction. A S. aureus positive control was also included each 
time PCR was performed. 
 
Results 
Twenty-five of thirty-one (81%) of the cows enrolled in the study tested qPCR positive 
for at least one pathogen targeted in the PathoProof assay from 0 to 30 days post treatment 
(DPT). Five cows were positive for non-target bacteria identified by MALDI-TOF MS and 
were not included in the final analysis study. These included Lactococcus garvieae (2), 
Enterobacter kobei (1), Enterococcus saccharolyticus (1), and Pseudomonas aeruginosa (1). 
One additional cow was not included in the study due to negative culture results on day 0 
despite a positive preliminary culture that was performed days before treatment by farm 
personnel. This brought the number of cows used in the final analysis to 25. Bacteria 
detected by qPCR from the remaining 25 cows included S. dysgalactiae (18), S. uberis (3), E. 
faecalis (1), E. coli (1) and coagulase-negative Staphylococcus spp. (4) including 
Staphylococcus simulans (1), Staphylococcus haemolyticus (2), and Staphylococcus 
chromogenes (1). Three cows were coinfected with 2 different bacteria based on day 0 milk 
cultures. These co-infections included S. dysgalactiae and S. haemolyticus, S. dysgalactiae 
 59 
and E. coli and E. faecalis and the algae Prototheca sp. (not a PathoProof target) confirmed 
by Gram stain. Over the course of 30 days, some samples were not collected due to cows 
ending their lactation cycle or removal from the herd. The distribution of cows and bacteria 
identified by MALDI-TOF MS is described in Table 2. 
Bacterial Culture 
Bacterial cultures with growth detected from any sample were included for 
identification by MALDI-TOF MS. Bacteria isolated from the 25 cows included in the study 
received MALDI-TOF MS scores greater than 2.0 with the exception of the S. dysgalactiae 
isolated from 14 DPT milk samples from cow 28. All 25 cows were positive by culture on 
day 0 with at least one bacterial species associated with bovine mastitis and included as a 
PathoProof target. Isolation of significant bacteria by culture markedly declined on days 3, 7, 
14 and 30 in cows that remained in the study. Less than 4 cows became culture positive again 
after day 0 (Table 3). All culture positive milk samples were PCR positive for PathoProof 
targets. 
Real-time PCR 
Twenty-five cows enrolled in the study were qPCR positive at 0 DPT for at least one 
target. Nineteen cows remained qPCR positive on 3 DPT. The number of positive cows 
decreased to 13 on day 7 and 14 and 6 cows on 30 DPT (Table 4). PCR and MALDI-TOF 
MS consistently detected the same bacteria when both culture and PCR were positive. 
Targets were detected by PathoProof qPCR with Cts ranging from 17.75 to 39.08 regardless 
of target. The average Ct for days 0 to 30 ranged from 29.13 to 35.25 and remained relatively 
steady from day 0 to day 30 on average.  
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 Two cows were consistently culture negative/qPCR positive for at least 1 PathoProof 
target on 3, 7, 14 and 30 DPT (Table 3). Four cows were culture negative/qPCR positive at 3 
DPT and then tested culture negative/PCR negative for the remainder of the study. Three 
cows were positive by PCR and negative by culture on days 3 and 7, and negative by both 
methods on days 14 and 30. Two cows were PCR positive and negative in culture on days 3, 
7, 14 and negative on day 30. Eight cows who were negative in culture for days 3, 7, 14 and 
30 had positive and negative PCR results on those days’ samples. Culture and PCR results 
throughout the 30 days of the study are depicted in Figure 1. 
 
Discussion 
Bacterial cultures from milk samples collected from cows with clinical mastitis are 
often negative for a variety of reasons although many unknown (Makovec and Ruegg, 2003; 
Oliveira et al., 2013). One explanation is the effect of antimicrobial therapy on the success of 
post-treatment bacterial cultures from milk samples. This study showed that PCR and 
bacterial culture outcomes are consistent prior to treatment and have the ability to detect 
similar pathogens. However, post-treatment, PCR detected at least one target bacteria in 
more milk samples compared to bacterial culture on days 3, 7, 14 and 30 post treatment 
(Figure 1). Only one of the 25 cows enrolled in the study was culture positive on day 3 while 
PCR detected bacterial targets included in the assay in 19 cows. The treatment regimens for 
all cows continued into day 5 making that result reasonable. Withdrawal times indicated by 
the antibiotic’s manufacturer indicate that the antibiotic may be present in the cow’s milk up 
to 72 hours after the last dose corresponding to day 6 in this study. With that, day 7 samples 
should be devoid of antibiotic, removing the added inhibitory elements preventing bacteria 
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from growing. Day 7 results showed 13 cows as culture negative/PCR positive and 1 cow 
positive for both culture and PCR indicating that there may be another force preventing 
bacteria from growing or the population is diminished to a level not detectable by culture. 
Days 14 and 30 had more culture negative/PCR positive cows, similar to days 3 and 7.  
Culture negative/PCR positive may also be attributed to PathoProof’s ability to detect 
bacterial DNA from dead and non-infectious bacteria. Cows may indeed have overcome the 
infection but still harbor DNA from the dead bacteria that once caused the infection. 
PathoProof PCR is not able to distinguish between live, infectious bacteria and dead, non-
infectious bacteria. It is possible that the assay could detect injured, non-infectious bacteria 
capable of repairing themselves and infecting or reinfecting the host however it still remains 
that the assay cannot determine the difference. 
 Questions remain as to the analytical sensitivity of PathoProof PCR in samples with 
low bacteria count and how PCR positive results should be interpreted from a clinical 
perspective. A sensitive mastitis diagnostic assay may be useful in the detection of bacteria 
from culture negative cows with low concentrations of bacteria due to chronic mastitis. 
Several pathogens associated with mastitis have been implicated in chronic and/or transient 
mastitis, most commonly S. aureus (Sears et al., 1990) but also E. coli (Döpfer et al., 1999), 
coagulase-negative staphylococci (Supré et al., 2011), S. uberis and S. dysgalactiae (Wyder 
et al., 2011). Chronic mastitis rotates through periods where clinical signs subside, SCC 
remains elevated, milk production remains low and pathogens are shed at a low rate (Döpfer 
et al., 1999). Low bacteria count has been overcome by some PCR assays reporting limit of 
detection (LOD) value of 102 CFU/mL (Riffon et al., 2001), and as low as 1 CFU/mL after 
including an enrichment step prior to PCR (Gillespie and Oliver, 2005). Previous studies 
 62 
using PathoProof PCR have studied quantitative results and its correlation with clinical 
mastitis. A previous study used a standard curve to detect a Ct of 22.2 that represented 
2.2x107 copies per mL of milk and was associated with clinical mastitis (Taponen et al., 
2009).  Another study used clinical milk samples to understand how Ct related to target 
sequence copy number using S. aureus (Hiitiö et al., 2015). However, an LOD using 
genomic copies and organism count in cfu/mL has not been published for PathoProof PCR. 
In our laboratory, the analytical sensitivity using serial dilutions of 3 organisms averaged 104 
cfu/mL as the limit of detection. This brings question about the sensitivity and its 
performance of the assay which is particularly problematic for pooled samples or bulk tank 
milk samples.  
 PathoProof PCR has been shown to detect S. aureus and coagulase negative 
staphylococci isolates originating from different mammalian species and geographic regions 
(Koskinen et al., 2009). However, when S. aureus is present in a sample the assay detects this 
as S. aureus and Staphylococcus species due to overlapping targets in the Staphylococcus 
genus and the S. aureus species. This presents a problem in the ability of detecting a non- 
Staphylococcus aureus species that may be present in a sample that also has S. aureus. The 
technician is not able to differentiate multiple Staphylococcus species in a sample if S. aureus 
is present whereas in culture two Staphylococcus species could be differentiated if they 
represent different phenotypes. 
 
Conclusion 
The results of this study suggest that PathoProof PCR may be useful to detect 
pathogens associated with bovine mastitis that are difficult to detect by culture. However, 
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qPCR results must be interpreted in the clinical context of individual cows. Real-time PCR 
has the capacity to be a quantitative assay although reference standards are necessary. If a 
similar experiment could be performed in a controlled fashion without some of the logistic 
issues a more accurate precedent could be made for use of the test. Additional research using 
a quantitative PCR assay and its correlation with clinical mastitis may indicate the future 
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Table 1. PathoProof Mastitis PCR targets included in each PCR reaction. 









 Enterococcus species   
 (including E. 
faecalis and  




 blaZ  













 Streptococcus uberis  
 IAC 
 Klebsiella species  
 (including K. 
oxytoca and K. 
pneumoniae)  
 Serratia marcescens 
 Trueperella 





Table 2. Bacteria isolated from milk samples collected prior to antibiotic treatment and 





























1 x (2 quarters)                       
2 x                        
3   x                      
4 x                         
5         x                
6     x                   
7 x   x                   
8 x                         
9                         
10       x                 
11   x                     
12 x                         
13                 x       
14                   x     
15                   x     
16 x                         
17 x                         
18   x                       
19                     x   
20               x         
21 x                         
22 x                         
23 x                         
24 x           x               
25 x                         
26 x                         
27 x                         
28 x                         
29 x                         
30             x         x   
31 x                         
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Table 4. Number of cows PathoProof qPCR positive on 0, 3, 7, 14 and 30 days post 
treatment. 
 



























34.24 3 of 10 31.21 
S. uberis 3 of 3 31.34 2 of 3 32.25 1 of 3 32.23 0 of 3 N/A 0 of 2 N/A 
Staph sp. 4 of 4 29.7 3 of 4 36.73 1 of 3 36.65 2 of 4 34.48 3 of 3 37.09 
E. coli 1 of 1 34.42 0 of 1 37.79 0 of 1 N/A 0 of 1 N/A 1 of 1 37.46 
E. faecalis 1 of 1 25.02 0 of 1 N/A 0 of 1 N/A 1 of 1 28.24 0 of 0 N/A 
Percent 
Positive  








 Pathogen Day 0 Day 3 Day 7 Day 14 Day 30 
S. dysgalactiae 18 of 18 0 of 18 1 of 16 2 of 16 1 of 10 
S. uberis 3 of 3 1 of 3 0 of 3  0 of 3 0 of 2 
Staph sp. 4 of 4 0 of 4 0 of 3  0 of 4 0 of 3 
E. coli 1 of 1 0 of 1  0 of 1 0 of 1  0 of 1  
E. faecalis 1 of 1 0 of 1  0 of 1  1 of 1 0 of 0 




























% Cows PCR Positive % Cows Culture Positive
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CHAPTER 5. GENERAL CONCLUSIONS 
 
Microbiological culture has performed well for the detection of bovine mastitis 
pathogens for decades in veterinary diagnostic laboratories. However, culture tests are time 
consuming and may be unable to grow fastidious organisms warranting new technologies. 
No other methods of detecting bovine mastitis pathogens are as multiplexed and rapid as 
PathoProof PCR. The 11 target bacteria of the assay cover a wide range of common mastitis 
pathogens. The purpose of evaluating this assay was to determine its strengths and 
weaknesses in sensitivity and specificity and its use with milk from cows being treated with 
intramammary antibiotics. 
 Analysis with well-validated culture isolates from bovine mastitis revealed a high 
specificity for target and non-target organisms. Analytical sensitivity or limit of detection 
determined with serial dilutions and standard plate count of pure culture isolates revealed an 
average LOD of 104 cfu/mL. Although an infectious dose for all mastitis-causing bacteria in 
the mammary gland has not been established, PathoProof’s LOD of 104 CFU/mL is relatively 
high with the potential of reporting false negatives. 
 PathoProof PCR was more successful detecting bacteria in milk from cows being 
treated for mastitis than culture. Cows sampled before treatment (day 0) and on days 3, 7, 14, 
and 30 post treatment initiation were negative for culture and positive for PCR on days 3, 7, 
14 and 30. Results do not necessarily mean infectious bacteria are still in the mammary gland 
but could also indicate a cow’s treatment has not been successful. 
Diagnostic laboratories may want to choose PathoProof PCR for select cases when 
bacterial growth may be inhibited. Further investigation into PathoProof’s sensitivity in 
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clinical samples and pooled samples such as bulk tank milk is necessary to better understand 
its capabilities. 
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APPENDIX: ADDITIONAL COW DATA 

































-/+ 26.9 -/+ 33.74 N/A N/A N/A N/A 





+/+ 23.33 -/+ 24.85 -/+ 28.66 -/+ 33.45 -/+ 35.26 
Teat lesion seen on 
D14 believed to be 





+/+ 31.57 -/- N/A -/- N/A -/- N/A -/- N/A 
Mycobacterium 
spp. Found after 
prolonged 




































+/+ 30.32 -/+ 37.13 -/- N/A -/- N/A N/A N/A 

































+/+ 24.05 +/+ 25.42 -/+ 32.23 -/- N/A N/A N/A 
No D30 sample, 
culture positive for 
























+/+ 18.31 -/+ 22.01 -/+ 22.68 -/+ 34.24 -/+ 34.56  

























+/+ 25.02 -/- N/A -/- N/A +/+ 28.24 N/A N/A 
No D30 and 
positive for 




+/+ 21.39 -/+ 33.24 N/A N/A -/+ 37.35 N/A N/A No D7 and D30 
 
